Skip to content
Screener

Gyre Therapeutics, Inc. GYRE Fair value adjustment of warrants

Fair value adjustment of warrants at other companies

Bloom Energy logo
Bloom EnergyBE
$25K—
Bloom Energy logo
Bloom EnergyBE
$3.95M—
Natera, Inc. logo
Natera, Inc.NTRA
-$166K+94.9%
AST SpaceMobile logo
AST SpaceMobileASTS
$1.17M-63.4%
Revolution Medicines, Inc. logo
Revolution Medicines, Inc.RVMD
$15.79M+747%
Carvana logo
CarvanaCVNA
$42M+127%

Segments

By segment

See full
Gyre-$132K+37.7%
Gyre Pharmaceuticals-$0—

Other financials

Income statement

See full
Revenue$29.1M-2.1%
Gross profit$26.9M-5.9%
Operating income-$14.4M-541%
Net income-$11.7M-471%
EPS (diluted)-$0.12-300%

Balance sheet

See full
Cash & equivalents$43.3M+18.6%
Total debt$3.4M+145%
Total equity$107.9M+17.3%
Total assets$199.3M+30.5%

Cash flow

See full
Operating cash flow-$16.7M-124%
CapEx$262.0K-21.8%
Free cash flow-$17.0M-118%

Valuation

See full
Market cap$712.55M+11.2%
Enterprise value$672.68M+11.0%
P/S6×-0.1×

Profitability

See full
Gross margin94.3%-1.7pp
Operating margin-14%-18.7pp
Net margin-13.4%-15.1pp
FCF margin-5.1%—

Returns & leverage

See full
Return on equity-16%-18.3pp
Debt / equity0×0.0×
Current ratio4.3×-1.1×